← Back to Search

Cardio-Oncology Consultations for Cancer (CARMA Trial)

N/A

Waitlist Available

Led By Katelyn Atkins, MD, PhD

Research Sponsored by Cedars-Sinai Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Planning to receive standard of care radiotherapy treatments

Have Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3 months

Awards & highlights

CARMA Trial Summary

This trial will look at how well people follow up with cardio-oncology consultations after being diagnosed with cancer.

Who is the study for?

This trial is for people with any stage of cancer (I-IV) who are about to receive high-dose radiotherapy (≥30 Gy) that includes the heart in its treatment area. Participants should be relatively active and mobile (ECOG 0-2), able to use a smart device, understand English, and follow study procedures.Check my eligibility

What is being tested?

The CARMA Trial is testing how well patients stick to a cardio-oncology consultation plan designed to reduce heart risks during thoracic radiotherapy treatments for cancer.See study design

What are the potential side effects?

Since this trial focuses on adherence to consultations rather than medication or invasive procedures, direct side effects from interventions may not apply. However, standard care radiotherapy itself can cause fatigue, skin reactions, or other organ-specific side effects.

CARMA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am planning to undergo standard radiotherapy treatments.

Select...

I can take care of myself and am up and about more than half of the day.

Select...

My cancer treatment includes high dose radiation affecting my heart.

CARMA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants who complete the cardio-oncology consultation visit

Secondary outcome measures

Evaluate participant intervention perspectives at the end of the study.

Number of participants who obtain blood pressure readings for at least 4 timepoints

Number of participants who obtain electrocardiogram (EKG) readings for at least 4 timepoints

+3 more

CARMA Trial Design

1Treatment groups

Experimental Treatment

Group I: CARMAExperimental Treatment1 Intervention

Cardiac Aggressive Risk MitigAtion plan with biosensor monitoring

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor

501 Previous Clinical Trials

164,873 Total Patients Enrolled

Katelyn Atkins, MD, PhDPrincipal InvestigatorCedars-Sinai Medical Center

1 Previous Clinical Trials

10 Total Patients Enrolled

Media Library

Cardiac Aggressive Risk MitigAtion Plan Clinical Trial Eligibility Overview. Trial Name: NCT05403736 — N/A

Cancer Clinical Trial 2023: Cardiac Aggressive Risk MitigAtion Plan Highlights & Side Effects. Trial Name: NCT05403736 — N/A

Cardiac Aggressive Risk MitigAtion Plan 2023 Treatment Timeline for Medical Study. Trial Name: NCT05403736 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent has participation in this research been realized?

"Indeed, clinicaltrials.gov provides evidence that this trial is actively recruiting participants. Initially posted on October 7th 2022, the study requires 20 individuals to be enrolled at two medical sites."

Answered by AI

Are there any unfilled slots available to participate in this trial?

"The clinical trial is currently searching for participants, per records on the clinicaltrials.gov website. This study was initially posted to the public domain on October 7th 2022 and was recently updated a few days ago - 10/10/2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial

Katelyn Atkins 2022. "Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05403736.